An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients

Authors
Category Primary study
Registry of TrialsJapan Primary Registry Network
Year 2022
This article has no abstract
Epistemonikos ID: 8dfddffe88b103684b7b38e11a38030324030cf9
First added on: Apr 11, 2025